Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Mutant IDH1 Inhibitor Ivosidenib (IVO; AG-120) in Combination with Azacitidine (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML)

Conference paper

DiNardo CD. et al, (2019), CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 19, S217 - S218

Chronic Lymphocytic Leukemia


Hallek M. et al, (2019)

Ibrutinib Plus Venetoclax in Relapsed/Refractory CLL: Results of the Bloodwise TAP Clarity Study

Conference paper

Munir T. et al, (2019), BRITISH JOURNAL OF HAEMATOLOGY, 185, 25 - 25

Load More